Organization Overview
Alternative names
baricitinib (olumiant) (1 trial)
capecitabine (xeloda) (2 trials)
cisplatin (platinol) (1 trial)
erlotinib (tarceva) (2 trials)
fluorouracil (efudex) (1 trial)
gemcitabine (gemzar) (2 trials)
Adenocarcinoma (Phase 2)
Asthma (Phase 4)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neurotoxicity Syndromes (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pneumonia (Phase 2)